3-Amino-6-bromopyridazine

Catalog No.: 
ACPYZX310
CAS No.: 
88497-27-2
Molecular Formula: 
C4H4BrN3
Molecular Weight: 
174.00
3-Amino-6-bromopyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$79.00In stockIn stock
100g97%$225.00In stockIn stock
500g97%$1091.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Amino-6-bromopyridazine
IUPAC Name6-bromopyridazin-3-amine
MDL No.MFCD01646092
Molecular FormulaC4H4BrN3
Molecular Weight174.00
SMILESNC1=CC=C(N=N1)Br
InChI KeyFXTDHDQFLZNYKW-UHFFFAOYSA-N
SynonymAC-28835 | 3-PYRIDAZINAMINE, 6-BROMO- | A842630 | EN300-175328 | FS-2572 | 6-BROMO-3-PYRIDAZINAMINE | PB12750 | AKOS006283227 | 3-Amino-6-bromopyridazine | SCHEMBL610333 | 6-bromopyridazin-3-amine | 6-bromopyridazine-3-amine | AM20120269 | J-511664 | STL5
CAS No.88497-27-2
PubChem CID2794779

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPYZX310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJGSQ357 route compound structure diagram
    ACJGSQ35717973-86-3In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACPYZX310 route product structure diagram
    ACPYZX31088497-27-2In Stock
Inquiry

2. ACPYZX310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJGSQ357 route compound structure diagram
    ACJGSQ35717973-86-3In Stock
  2. Then
  3. ACPYZX310 route product structure diagram
    ACPYZX31088497-27-2In Stock
Inquiry

3. ACPYZX310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYZX310 route product structure diagram
    ACPYZX31088497-27-2In Stock
Inquiry

Comments (0)